Resvita Bio
Berkeley
About Resvita Bio
Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.3M
- Funding stage: Seed
- Last round: Grant (Sep 2024)
- Website: resvitabio.com
Industries & Categories
Biotechnology, Health Care, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/resvita-bio-62569 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.